Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows todayheadline
Researchers, in a sense, manipulated each patient’s cancer in an attempt to prevent it from coming back. Read More
Read moreDetailsTag: Merck
Why Merck Stock Is Plummeting Today todayheadline
Shares of Merck (MRK -9.62%) were trading lower on Tuesday. The company's stock had lost 10.1% as of 2 p.m. ...
Read moreDetails
Merck snags Chinese obesity drug in nearly $2 billion deal todayheadline
Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. ...
Read moreDetails
